Enovis ENOV Bracing and Support — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Enovis in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enovis's bracing and support — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enovis's bracing and support — net sales?
- Enovis (ENOV) reported bracing and support — net sales of $114.88M in Q1 2026.
- How has Enovis's bracing and support — net sales changed year-over-year?
- Enovis's bracing and support — net sales decreased by 0.2% year-over-year, from $115.09M to $114.88M.
- What is the long-term trend for Enovis's bracing and support — net sales?
- Over 4 years (2021 to 2025), Enovis's bracing and support — net sales has grown at a 2.9% compound annual growth rate (CAGR), from $432.96M to $486.24M.
- What does bracing and support — net sales mean?
- This metric represents the total revenue generated from the sale of bracing and support medical devices, net of returns, allowances, and discounts. It serves as a primary indicator of market demand and commercial performance for the company's orthopedic and rehabilitation product portfolio. Tracking this figure allows investors to assess the growth trajectory and competitive positioning of the company's non-surgical intervention business segment.